Transmission of cerebral amyloid pathology by peripheral administration of misfolded Aβ aggregates.
Rodrigo MoralesJaviera Bravo-AlegriaInes Moreno-GonzalezClaudia Duran-AniotzNazaret GamezGeorge Edwards IiiClaudio SotoPublished in: Molecular psychiatry (2021)
Previous reports showed that brain Aβ amyloidosis can be induced in animal models by exogenous administration of pre-formed aggregates. To date, only intra-peritoneal and intra-venous administrations are described as effective means to peripherally accelerate brain Aβ amyloidosis by seeding. Here, we show that cerebral accumulation of Aβ can be accelerated after exposing mouse models of Alzheimer's disease (AD) to Aβ seeds by different peripheral routes of administration, including intra-peritoneal and intra-muscular. Interestingly, animals receiving drops of brain homogenate laden with Aβ seeds in the eyes were efficiently induced. On the contrary, oral administration of large quantities of brain extracts from aged transgenic mice and AD patients did not have any effect in brain pathology. Importantly, pathological induction by peripheral administration of Aβ seeds generated a large proportion of aggregates in blood vessels, suggesting vascular transport. This information highlights the role of peripheral tissues and body fluids in AD-related pathological changes.
Keyphrases
- resting state
- white matter
- cerebral ischemia
- functional connectivity
- subarachnoid hemorrhage
- gene expression
- healthcare
- chemotherapy induced
- end stage renal disease
- high glucose
- emergency department
- ejection fraction
- multiple sclerosis
- drug induced
- cognitive decline
- multiple myeloma
- prognostic factors
- endothelial cells
- patient reported outcomes
- mild cognitive impairment
- cerebral blood flow